Key Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Key Financial's VRTX Position: Q3 2026 in Review
Key Financial increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q3 2026, buying an estimated $1.54K and bringing the position to 293 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #336.
Key Financial first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Key Financial held 293 shares of Vertex Pharmaceuticals worth $153K as of Q3 2026.
- Key Financial bought 3 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.54K.
- Vertex Pharmaceuticals made up 0.03% of Key Financial's portfolio in Q3 2026, its #336 holding.
- Key Financial first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.